Fluid Intake in the First Week of Life and the Duration of Hemodynamically Significant Patent Ductus Arteriosus in Extremely Preterm Infants

Abstract

Objective This study aimed to determine the association between daily fluid intake and the duration of hemodynamically significant patent ductus arteriosus (hsPDA).

Study Design This is a retrospective cohort study of extremely preterm infants (<29 weeks) admitted in the Neonatal Intensive Care Unit of the Advent Health for Children from January 2013 to March 2016, if hsPDA was diagnosed in first week of life and serial echocardiograms were available. Diagnosis of hsPDA was based on a scoring system and its duration was estimated from serial echocardiograms. Cohort was divided into two groups based on duration of hsPDA (<1week, group A and ≥1 week, group B). Daily fluid intake was categorized as prescribed and actual. Prescribed volume was ordered by clinicians based on birth weight, not including trophic feeds, intravenous (IV) boluses or transfusions, etc. Actual intake was calculated by the electronic medical records based on daily weights and included all enteral or parenteral fluids. Multivariate analysis was performed to determine an association between total daily fluid intake over the first week of life and the duration of hsPDA. Two groups were compared to observe the difference between prescribed and actual daily fluid intakes.

Results We enrolled 50 infants in group A and 76 in group B. Infants in group B were of significantly lower gestation and required prolonged ventilation and hospitalization. An association between higher fluid intake in the first 2 days of life and prolonged duration of hsPDA was confirmed by multivariate analysis. Actual fluid intake was significantly higher than prescribed total fluid intake in first 4 days of life for infants in both groups.

Conclusion In extremely preterm infants, higher fluid intake in first 2 days of life is associated with prolonged duration of hsPDA. Actual daily fluid intake can be significantly higher than prescribed daily fluids due to daily weight changes and additional fluid administration.

Key Points

• In preterm infants, actual daily fluid intake may be higher than prescribed volume.

• Higher daily fluid intake in first week of life is associated with prolonged duration of PDA.

• PDA scoring system can be helpful for objective assessment of PDA in preterm infants.

Keywords

PDA - extremely preterm infants - total daily fluid intake

Publikationsverlauf

Eingereicht: 08. August 2021

Angenommen: 09. August 2021

Accepted Manuscript online:
12. August 2021

Artikel online veröffentlicht:
23. November 2021

• References

• 1 Rolland A, Shankar-Aguilera S, Diomandé D, Zupan-Simunek V, Boileau P. Natural evolution of patent ductus arteriosus in the extremely preterm infant. Arch Dis Child Fetal Neonatal Ed 2015; 100 (01) F55-F58
• 2 Heuchan AM, Clyman RI. Managing the patent ductus arteriosus: current treatment options. Arch Dis Child Fetal Neonatal Ed 2014; 99 (05) F431-F436
• 3 Hermes-DeSantis ER, Clyman RI. Patent ductus arteriosus: pathophysiology and management. J Perinatol 2006; 26 (Suppl. 01) S14-S18 , discussion S22–S23
• 4 Tsui I, Ebani E, Rosenberg JB, Lin J, Angert RM, Mian U. Patent ductus arteriosus and indomethacin treatment as independent risk factors for plus disease in retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 2013; 50 (02) 88-92
• 5 Mirea L, Sankaran K, Seshia M. et al; Canadian Neonatal Network. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias. J Pediatr 2012; 161 (04) 689-94.e1 , e681
• 6 Madan JC, Kendrick D, Hagadorn JI, Frantz III ID. National Institute of Child Health and Human Development Neonatal Research Network. Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome. Pediatrics 2009; 123 (02) 674-681
• 7 Clyman R, Cassady G, Kirklin JK, Collins M, Philips III JB. The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial. J Pediatr 2009; 154 (06) 873-876
• 8 Abdel-Hady H, Nasef N, Shabaan AE, Nour I. Patent ductus arteriosus in preterm infants: do we have the right answers?. BioMed Res Int 2013; 2013: 676192
• 9 Letshwiti JB, Semberova J, Pichova K, Dempsey EM, Franklin OM, Miletin J. A conservative treatment of patent ductus arteriosus in very low birth weight infants. Early Hum Dev 2017; 104: 45-49
• 10 Ezenwa B, Pena E, Schlegel A, Bapat R, Shepherd EG, Nelin LD. Effects of practice change on outcomes of extremely preterm infants with patent ductus arteriosus. Acta Paediatr 2019; 108 (01) 88-93
• 11 Wyllie JP, Gupta S. Prophylactic and early targeted treatment of patent ductus arteriosus. Semin Fetal Neonatal Med 2018; 23 (04) 250-254
• 12 Lee JA. Practice for preterm patent ductus arteriosus; focusing on the hemodynamic significance and the impact on the neonatal outcomes. Korean J Pediatr 2019; 62 (07) 245-251
• 13 Sehgal A, Paul E, Menahem S. Functional echocardiography in staging for ductal disease severity: role in predicting outcomes. Eur J Pediatr 2013; 172 (02) 179-184
• 14 Mirza H, Garcia J, McKinley G. et al. Duration of significant patent ductus arteriosus and bronchopulmonary dysplasia in extremely preterm infants. J Perinatol 2019; 39 (12) 1648-1655
• 15 Warburton D, Bell EF, Stonestreet BS, Oh W. Echocardiographic effects of high and low volumes of maintenance fluid administration in low-birth-weight infants. Dev Pharmacol Ther 1983; 6 (01) 45-54
• 16 Bell EF, Oh W. Water requirement of premature newborn infants. Acta Paediatr Scand Suppl 1983; 305: 21-26
• 17 Bell EF, Warburton D, Stonestreet BS, Oh W. Effect of fluid administration on the development of symptomatic patent ductus arteriosus and congestive heart failure in premature infants. N Engl J Med 1980; 302 (11) 598-604
• 18 Abbas S, Keir AK. In preterm infants, does fluid restriction, as opposed to liberal fluid prescription, reduce the risk of important morbidities and mortality?. J Paediatr Child Health 2019; 55 (07) 860-866
• 19 Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2014; (12) CD000503
• 20 Oh W, Poindexter BB, Perritt R. et al; Neonatal Research Network. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. J Pediatr 2005; 147 (06) 786-790
• 21 Agnoli GC, Borgatti R, Cacciari M, Lenzi P, Marinelli M, Stipo L. Renal synthesis of prostacyclin and thromboxane in healthy women: differential effects of a short-term saline loading. Prostaglandins Leukot Essent Fatty Acids 2000; 62 (02) 111-117
• 22 Tan SY, Sandwisch DW, Mulrow PJ. Sodium intake as a determinant of urinary prostaglandin E2 excretion. Prostaglandins Med 1980; 4 (01) 53-63
• 23 Reller MD, Lorenz JM, Kotagal UR, Meyer RA, Kaplan S. Hemodynamically significant PDA: an echocardiographic and clinical assessment of incidence, natural history, and outcome in very low birth weight infants maintained in negative fluid balance. Pediatr Cardiol 1985; 6 (01) 17-23
• 24 Verma RP, Shibli S, Fang H, Komaroff E. Clinical determinants and utility of early postnatal maximum weight loss in fluid management of extremely low birth weight infants. Early Hum Dev 2009; 85 (01) 59-64
• 25 Warnock A, Szatkowski L, Lakshmanan A, Lee L, Kelsall W. Surgical management of patent ductus arteriosus in pre-term infants - a british paediatric surveillance study. BMC Pediatr 2021; 21 (01) 270